AML
Gilteritinib and Allo HSCT Together Increase Survival in FLT3-Mutated AML
SG Tylor
Results from a real-world study presented at the European Society for Blood and Marrow Transplantation (EBMT) 49th Annual Meeting indicate ...
Ziftomenib: A Promising New Treatment for NPM1-Mutated Acute Myeloid Leukemia
SG Tylor
Kura Oncology’s recent presentation at the European Hematology Association (EHA) 2023 conference highlighted the impressive clinical potential of ziftomenib in ...
